ATRX and neoplasm: Studies indicate that ATRX deficiency alters the tumor microenvironment by inducing innate immune responses to dsRNA, upregulating chemokines such as CCL2, CCL5, CXCL10 and IFNβ in innate immune pathways, and enhancing immune CD4+Tcell infiltration (Hariharan et al., 2024).